Thymol and carvacrol, two main components of thyme, have several valuable effects on the immune system. This study aims to evaluate the effects of these components on T-helper (T-H) cell responses and their subsets in mice immunized with ovalbumin. The effects of these components on: a specific in vivo immune response were evaluated by assessing changes in delayed-type hypersensitivity (DTH); ex vivo splenocyte proliferative responses were evaluated using a BrdU assay gene expression of cytokines and key transcription factors involved in T-cells subset differentiation among the mouse splenocytes were assessed using real-time polymerase chain reaction (PCR); and splenocyte cytokine formation (ex vivo) and levels of the cytokines in mouse sera were measured by ELISA. Mice treated with thymol or carvacrol had reduced DTH responses (26% and 50%, respectively) compared with control mice. Thymol and carvacrol each diminished splenocyte proliferation to nearly 65-72% of control levels (p<0.01). These agents also led to decreased T(H)1 [interleukin (IL)-2, interferon (IFN)-)], T(H)2 (IL-4) and T(H)17 (IL-17A) levels in the splenocyte cultures and in the sera of mice but increased levels of IL-10 and transforming growth factor (TGF)-. Treated immunized mice showed significantly reduced T-box 21 (T-bet) expression from 3.8 [+/- 0.3]-fold in untreated ovalbumin-immunized mice to 0.9 [+/- 0.4]-(thymol) and 0.8 [+/- 0.2]-fold (carvacrol) (p<0.01). GATA binding protein 3 (GATA-3) expression declined from 3.4 [+/- 0.4]- to 0.5 [+/- 0.3]-fold (thymol) and 0.6 [+/- 0.4]-fold (carvacrol), whereas RORc decreased from 13.4 [+/- 1.6]- to 1.5 [+/- 0.6]-fold (thymol) and 0.8 [+/- 0.4]-fold (carvacrol) (p<0.001). As carvacrol and thymol each suppressed the antigen-specific immune response by reducing T-H cell-related cytokines\specific transcription factors, this indicated their potential to modulate destructive immune responses attributed to T-cells over-activation.